Role of Permissive Neuraminidase Mutations in Influenza A/Brisbane/59/2007-like (H1N1) Viruses

English version České info

Neuraminidase (NA) mutations conferring resistance to NA inhibitors were believed to compromise influenza virus fitness. Unexpectedly, an oseltamivir-resistant A/Brisbane/59/2007 (Bris07)-like H1N1 H275Y NA variant emerged in 2007 and completely replaced the wild-type (WT) strain in 2008–2009. The NA of such variant contained additional NA changes (R222Q, V234M and D344N) that potentially counteracted the detrimental effect of the H275Y mutation on viral fitness. Here, we rescued a recombinant Bris07-like WT virus and 4 NA mutants/revertants (H275Y, H275Y/Q222R, H275Y/M234V and H275Y/N344D) and characterized them in vitro and in ferrets. A fluorometric-based NA assay was used to determine Vmax and Km values. Replicative capacities were evaluated by yield assays in ST6Gal1-MDCK cells. Recombinant NA proteins were expressed in 293T cells and surface NA activity was determined. Infectivity and contact transmission experiments were evaluated for the WT, H275Y and H275Y/Q222R recombinants in ferrets. The H275Y mutation did not significantly alter Km and Vmax values compared to WT. The H275Y/N344D mutant had a reduced affinity (Km of 50 vs 12 µM) whereas the H275Y/M234V mutant had a reduced activity (22 vs 28 U/sec). In contrast, the H275Y/Q222R mutant showed a significant decrease of both affinity (40 µM) and activity (7 U/sec). The WT, H275Y, H275Y/M234V and H275Y/N344D recombinants had comparable replicative capacities contrasting with H275Y/Q222R mutant whose viral titers were significantly reduced. All studied mutations reduced the cell surface NA activity compared to WT with the maximum reduction being obtained for the H275Y/Q222R mutant. Comparable infectivity and transmissibility were seen between the WT and the H275Y mutant in ferrets whereas the H275Y/Q222R mutant was associated with significantly lower lung viral titers. In conclusion, the Q222R reversion mutation compromised Bris07-like H1N1 virus in vitro and in vivo. Thus, the R222Q NA mutation present in the WT virus may have facilitated the emergence of NAI-resistant Bris07 variants.

Vyšlo v časopise: Role of Permissive Neuraminidase Mutations in Influenza A/Brisbane/59/2007-like (H1N1) Viruses. PLoS Pathog 7(12): e32767. doi:10.1371/journal.ppat.1002431
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002431

Souhrn

Zdroje

1. ReidAHFanningTGJanczewskiTATaubenbergerJK 2000 Characterization of the 1918 “Spanish” influenza virus neuraminidase gene. Proc Natl Acad Sci U S A 97 6785 6790

2. BoltzDAAldridgeJRJrWebsterRGGovorkovaEA 2010 Drugs in development for influenza. Drugs 70 1349 1362

3. ColmanPMHoynePALawrenceMC 1993 Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J Virol 67 2972 2980

4. LackenbyAHungnesODudmanSGMeijerAPagetWJ 2008 Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. 13 Euro Surveill pii: 8026

5. HurtACErnestJDengYMIannelloPBesselaarTG 2009 Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res 83 90 93

6. HaugeSHDudmanSBorgenKLackenbyAHungnesO 2009 Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 15 155 162

7. DharanNJGubarevaLVMeyerJJOkomo-AdhiamboMMcClintonRC 2009 Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. Jama 301 1034 1041

8. HerlocherMLTrusconREliasSYenHLRobertsNA 2004 Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 190 1627 1630

9. IvesJACarrJAMendelDBTaiCYLambkinR 2002 The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res 55 307 317

10. BazMAbedYSimonPHamelinMEBoivinG 2010 Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis 201 740 745

11. Rameix-WeltiMAEnoufVCuvelierFJeanninPvan der WerfS 2008 Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog 4 e1000103

12. CollinsPJHaireLFLinYPLiuJRussellRJ 2009 Structural basis for oseltamivir resistance of influenza viruses. Vaccine 27 6317 6323

13. BloomJDGongLIBaltimoreD 2010 Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328 1272 1275

14. HaydenFGPaleseP 2002 Influenza virus. DouglasRWJRichmanDHaydenFG Clinical Virology. 2nd edition. Washington DC ASM Press 891 920

15. PalesePCompansRW 1976 Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol 33 159 163

16. HensleySEDasSRGibbsJSBaileyALSchmidtLM 2011 Influenza a virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. PLoS One 6 e15190

17. RussellRJHaireLFStevensDJCollinsPJLinYP 2006 The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443 45 49

18. KryazhimskiySDushoffJBazykinGAPlotkinJB 2011 Prevalence of epistasis in the evolution of influenza a surface proteins. PLoS Genet 7 e1001301

19. YangJRLinYCHuangYPSuCHLoJ 2011 Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009. PLoS One 6 e18177

20. BloomJDNayakJSBaltimoreD 2011 A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase. PLoS One 6 e22201

21. HoffmannEStechJGuanYWebsterRGPerezDR 2001 Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146 2275 2289

22. LiuQWangSMaGPuJForbesNE 2009 Improved and simplified recombineering approach for influenza virus reverse genetics. J Mol Genet Med 3 225 231

23. AbedYBazMBoivinG 2006 Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds. Antivir Ther 11 971 976

24. DuanSBoltzDASeilerPLiJBragstadK 2010 Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog 6 e1001022

25. PizzornoABouhyXAbedYBoivinG 2011 Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors. J Infect Dis 203 25 31

26. AbedYGoyetteNBoivinG 2004 A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus. Antivir Ther 9 577 581

27. HamelinMEBazMAbedYCoutureCJoubertP 2010 Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog 6 e1001015